Search results for: 'dure access control'

This study covers U.S. markets for venous access devices including peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports, and catheter securement devices. This combination of new technology and expanding patient population will drive venous access catheters into significant growth th...

The widespread outbreak of COVID-19 across the world has overburdened hospitals with a huge influx of patients. Traditional hospitals that rely on manual and analog methods have been unable to handle the huge patient load with limited resources and this has severely impacted the ability of hospitals to provide quality care to patients. To address t...

Research shows that environmental surfaces in healthcare settings play a crucial role in pathogen transmission, leading to healthcare-acquired infections (HAIs), which have a considerable cost burden. Outpatient settings also pose significant infection risks. In the United States, millions of patients frequent outpatient facilities such as ambulato...

The cardiac monitoring market will benefit from healthcare delivery challenges by promoting advanced monitoring solutions that help providers reduce 30-day readmissions for cardiac-associated conditions. Interest in the remote patient monitoring space is altering portfolio approaches across products and services. Changes in payments, particularly g...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

Mental health illness is one of the most common disorders globally. The poor accessibility and high cost of the conventional face-to-face mental health therapy has created a huge treatment gap, and digital technologies help bridge this gap. Digital technologies play an important role in supporting and treating mental health conditions. Digital plat...

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...

Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...